| Home > Research > Research Publications |
 |
|
|||||
Staff Reports |
|||||
|
|||||
What Do Drug Monopolies Cost Consumers in Developing Countries? |
|||||
|
|||||
| December 2011 Number 530 |
| JEL classification: D4, F13, L1, L65, O34 |
|
|
Author: Rebecca Hellerstein This paper quantifies the effects of drug monopolies and low per-capita income on pharmaceutical prices in developing economies using the example of the antiretroviral drugs (ARVs) used to treat HIV.
Available only in PDF
|
|
|||||
|
|
|
|||
|
|||||
|
|||||
|
|
|
|||
|
|||||
|
|
|||||||||||||||
|
|||||||||||||||
